Respiratory Pharmacology Module Flashcards
Name the main beta2-receptor agonists used in Asthma treatment
Salbutamol (SABA), terbutaline (SABA)
Salmeterol (LABA), eformoterol (LABA)
Indacaterol (Ultra-LABA)
What is the MOA of respiratory Beta2-agonists?
Binding of B2 agonist to beta2 adrenoceptor > activation of Gs protein (GPCR) > ATP is converted into cAMP > protein kinase (PK) conversion into protein kinase A (PKA) > relaxation of smooth muscle
Name and explain some issues with B2-adrenoceptor agonists
- Chronic, high dose exposure = enhance Th2 inflammatory pathway through IL-12 and IFN-gamma inhibition. Also increase airway hyperresponsiveness
- Pre-treatment with B2-adrenoceptor agonist = increased severity of late asthma
- Continuous treatment without inhaled corticosteroids (ICS) = Increased sputum eosinophils
How long approximately do SABAs take to work?
<5 mins (salbutamol, terbutaline)
How long approximately is the half-life of the SABAs?
3-6 hrs (salbutamol)
4-6 (terbutaline)
What is the onset of action for LABAs?
Salmeterol = 15 mins
Formoterol= 7 mins
Olodaterol, Vilanterol = 5 mins
What is the duration of action/half life of the LABAs?
All 12 hours
What is the half life and onset of action for the Ultra-LABA?
Half life = 24 hours
Onset of Action = 5 mins
What are the indications for B2-agonists?
SABAs = Symptom relief of asthma and COPD, prevention of exercise induce bronchoconstriction
LABAs = Maintenance treatment of asthma with ICS, COPD
Name some B2-agonist ADR
Tremor (B1 activation), Palpitations (b2 activation), tachycardia, agitation, insomnia = beta1 activation
Hyperglycaemia (due to sympathetic response), hypokalaemia = as insulin exits cells into blood it will be exchanged for K+
- Hypokalaemia worsened by = xanthines, steroids, diuretics
Lactic acidosis (high IV dose), Urticaria, angioedema
Hyperactivity in children, headache, muscle cramps
Name the relevant inhaled corticosteroids (ICS)
Beclomethasone dipropionate, budesonide, ciclosonide, fluticasone
Prednisone (metabolised in the liver to prednisolone)
Based on oral bioavailability and lung delivery, what are the better ICS?
Ciclesonide = lung deliver (50%), F (<1/<1)
Fluticasone = lung delivery (20%), F (</=1)
Mometasone furoate = lung delivery (11%), F (<1)
Briefly explain the MOA of ICS
Corticosteroid acts on glucocorticoid receptor > transactivation (Anti-inflammatories), cis-repression (causes side effects), trans-repression (inflammatory signals/proteins = enzymes, receptors, proteins, cytokines, chemokines)
Basically, entering into the nucleus and causing a series of gene activations and repressions
In the context of asthma, what are some wanted outcomes/effects of ICS?
Increase b2 receptor expression, decrease Th2 cell counts, downregulate PGD2 (reducing bronchoconstriction)
Name some inhaled corticosteroid adverse reactions
Common= Dystonia (talk different/deeper voice), oropharyngeal candidiasis, bruising, facial skin irritations
Rare = allergic reactions (bronchospasm, rash, urticaria)
Potential for systemic effects = dose, duration, and drug interaction dependent
Name some of the systemic ADRs seen with corticosteroids
Psychological effects = headache, mental disturbances (euphoria/depression), altered mood, insomnia (cortisol is physiologically low at night, the drug will increase it at night causing insomnia)
Phenotypical effects = skin atrophy, fat redistribution, acne, hirsutism, cataracts (increased intraocular pressure)
Immune effects = masking of infection, increased risk of infection
Other = hypokalaemia, hyperglycaemia, sodium and water retention, adrenal suppression, osteoporosis
Which receptor is targeted by the Cysteinyl leukotrienes (CystLT)?
CysLT1 receptor
Names the CystLT receptor antagonists used in asthma
Montelukast (once daily), Zafirlukast (twice daily)
What is the MOA of CysLT receptor antagonists?
competitive antagonising of CysLT1 receptor > inhibiting cysteinyl leukotrienes
What are the indication/s or uses for CysLT receptor antagonists in asthma?
Exercise-induced asthma
Decreases early and late responses to inhaled allergens
Can be used as add-on therapy with B2-agonists (have an additive effect) and ICS
What are CysLT not indicated for?
Reversal of bronchospasms
Name some ADRs seen with CysLT receptor antagonist use
Headaches, dizziness
Neuropsychiatric effects (potential suicidality = issue in kids)
- Mood or behavioural effects (anxiety, depression, aggression, irritability)
- Insomnia, nightmares, sleepwalking, tremor, hallucinations
Nausea, abdominal pain, Diarrhoea
Hypersensitivity reaction (rash, anaphylaxis, angioedema)
Name the mast cell stabilisers used in asthma treatment
Cromoglicate, nedrocromil
Describe the MOA of mast cell stabilisers
Prevent histamine release from mast cells through stabilising the mast cell’s membrane, making it stronger and less likely to break.